Literature DB >> 21510666

Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity.

Sean C Gay1, Haoming Zhang, P Ross Wilderman, Arthur G Roberts, Tong Liu, Sheng Li, Hsia-Lien Lin, Qinghai Zhang, Virgil L Woods, C David Stout, Paul F Hollenberg, James R Halpert.   

Abstract

A combined structural and computational analysis of rabbit cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene (tBPA) has yielded insight into how the enzyme retains partial activity. Since conjugation to tBPA modifies a highly conserved active site residue, the residual activity of tBPA-labeled 2B4 observed in previous studies was puzzling. Here we describe the first crystal structures of a modified mammalian P450, which show an oxygenated metabolite of tBPA conjugated to Thr 302 of helix I. These results are consistent with previous studies that identified Thr 302 as the site of conjugation. In each structure, the core of 2B4 remains unchanged, but the arrangement of plastic regions differs. This results in one structure that is compact and closed. In this conformation, tBPA points toward helix B', making a 31° angle with the heme plane. This conformation is in agreement with previously performed in silico experiments. However, dimerization of 2B4 in the other structure, which is caused by movement of the B/C loop and helices F through G, alters the position of tBPA. In this case, tBPA lies almost parallel to the heme plane due to the presence of helix F' of the opposite monomer entering the active site to stabilize the dimer. However, docking experiments using this open form show that tBPA is able to rotate upward to give testosterone and 7-ethoxy-4-trifluoromethylcoumarin access to the heme, which could explain the previously observed partial activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21510666      PMCID: PMC3105221          DOI: 10.1021/bi200482g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  The structure of CYP101D2 unveils a potential path for substrate entry into the active site.

Authors:  Wen Yang; Stephen G Bell; Hui Wang; Weihong Zhou; Mark Bartlam; Luet-Lok Wong; Zihe Rao
Journal:  Biochem J       Date:  2011-01-01       Impact factor: 3.857

2.  Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction.

Authors:  Yonghong Zhao; Mark A White; B K Muralidhara; Ling Sun; James R Halpert; C David Stout
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

3.  Conformational flexibility of mammalian cytochrome P450 2B4 in binding imidazole inhibitors with different ring chemistry and side chains. Solution thermodynamics and molecular modeling.

Authors:  B K Muralidhara; Surendra Negi; Christopher C Chin; Werner Braun; James R Halpert
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

4.  Effect of conformational dynamics on substrate recognition and specificity as probed by the introduction of a de novo disulfide bond into cytochrome P450 2B1.

Authors:  Haoming Zhang; Cesar Kenaan; Djemel Hamdane; Gaston Hui Bon Hoa; Paul F Hollenberg
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

5.  Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism.

Authors:  Shingo Nagano; Thomas L Poulos
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

6.  Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme.

Authors:  Cynthia E Hernandez; Santosh Kumar; Hong Liu; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2006-09-25       Impact factor: 4.013

7.  Molecular basis for a functionally unique cytochrome P450IIB1 variant.

Authors:  K M Kedzie; C A Balfour; G Y Escobar; S W Grimm; Y A He; D J Pepperl; J W Regan; J C Stevens; J R Halpert
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.

Authors:  Hsia-Lien Lin; Haoming Zhang; Kathleen R Noon; Paul F Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  2009-08-21       Impact factor: 4.030

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  23 in total

1.  Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene.

Authors:  Hsia-lien Lin; Haoming Zhang; Matthew J Pratt-Hyatt; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2011-09-19       Impact factor: 3.922

Review 2.  New amphiphiles for membrane protein structural biology.

Authors:  Qinghai Zhang; Houchao Tao; Wen-Xu Hong
Journal:  Methods       Date:  2011-09-20       Impact factor: 3.608

3.  Functional importance of a peripheral pocket in mammalian cytochrome P450 2B enzymes.

Authors:  Hyun-Hee Jang; Jingbao Liu; Ga-Young Lee; James R Halpert; P Ross Wilderman
Journal:  Arch Biochem Biophys       Date:  2015-08-28       Impact factor: 4.013

Review 4.  Structural diversity of eukaryotic membrane cytochrome p450s.

Authors:  Eric F Johnson; C David Stout
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

5.  The role of cytochrome P450 2B6 and 2B4 substrate access channel residues predicted based on crystal structures of the amlodipine complexes.

Authors:  Hyun-Hee Jang; Dmitri R Davydov; Ga-Young Lee; Chul-Ho Yun; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2014-01-18       Impact factor: 4.013

Review 6.  Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.

Authors:  Paul R Ortiz de Montellano
Journal:  Drug Metab Rev       Date:  2019-07-07       Impact factor: 4.518

Review 7.  Plasticity of CYP2B enzymes: structural and solution biophysical methods.

Authors:  P Ross Wilderman; James R Halpert
Journal:  Curr Drug Metab       Date:  2012-02       Impact factor: 3.731

8.  So many roads traveled: A career in science and administration.

Authors:  James R Halpert
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

9.  Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules.

Authors:  Manish B Shah; P Ross Wilderman; Jaime Pascual; Qinghai Zhang; C David Stout; James R Halpert
Journal:  Biochemistry       Date:  2012-09-04       Impact factor: 3.162

10.  Steroid-based facial amphiphiles for stabilization and crystallization of membrane proteins.

Authors:  Sung Chang Lee; Brad C Bennett; Wen-Xu Hong; Yu Fu; Kent A Baker; Julien Marcoux; Carol V Robinson; Andrew B Ward; James R Halpert; Raymond C Stevens; Charles David Stout; Mark J Yeager; Qinghai Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.